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Letters to the EditorCONTINUOUS TRACHEAL
INTUBATION IN PATIENTS
WITH MYASTHENIA GRAVIS
AFTER THYMECTOMY TO
PREVENT TRACHEAL
INCISION FOR MYASTHENIC
CRISIS
To the Editor:
We read the article byWatanabe and
colleagues1 with great interest. In the
article the authors analyzed 122 pa-
tients who underwent transsternal thy-
mectomy and found that myasthenic
crisis was affected by the existence
of preoperative bulbar symptoms,
a history of preoperative myasthenic
crisis, a preoperative serum level of
antiacetylcholine receptor antibody
of greater than 100 nmol/L, and intra-
operative blood loss of greater than
1000 mL. They concluded that metic-
ulous preoperative and postoperative
care should be carried out to prevent
postoperative myasthenic crisis in pa-
tients with these prognostic factors.
Herein we present tips on continu-
ous tracheal intubation in patients
with myasthenia gravis after thymec-
tomy to prevent tracheal incision for
myasthenic crisis. We separated 236
patients with myasthenia gravis who
had undergone thymectomy by means
of video-assisted thoracoscopic sur-
gery into 2 groups. We prospectively
continued tracheal intubation to 48
hours in group A (120 patients). The
other 116 patients in group B refused
the procedures and were regarded as
negative control subjects. We found
that the strong predictors of myasthe-
nia crisis included pulmonary compli-
cations, Osserman typing of IIb or
greater,malignant thymoma, andapre-
operative oral dose of pyridostigmine
bromide of greater than 480 mg/d.
There were not any differences regard-
ing the incidence rate of myasthenia
crisis between groups A and B. How-
ever, the requirement of tracheal inci-
sion in group A was much lower than
in group B (10% vs 29.3%, P<.01)
because most of the crisis happened
postoperatively in 48 hours and
continuous intubation could support240 The Journal of Thoracic and Cmany patients until attenuation of the
symptoms.
As a result, we think that postoper-
ative continuous tracheal intubation to
48 hours is necessary for those pa-
tients with myasthenia gravis who
are prone to crisis.
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We would like to congratulate Deng
and colleagues on their letter with com-
ments on our article,1 especially on the
comparison of the outcomes between
the 2 studies. First of all, we have to un-
derstand that the surgical approach of
our study has major differences from
their study. In our study extended
thymectomy through a median sternot-
omy was performed, whereas thymec-
tomy by means of video-assisted
thoracoscopic surgery was their tech-
nique. The incidence of tracheostomy
was 1.6% (2/122) for our study com-
pared with 10% in the intervention
group for their study. We attributed the
difference in indication for tracheos-
tomy to the different incidence results.
Tracheal intubation or noninvasive ven-
tilation2 was maintained in our patients
for at least 7 dayswhen no inherent pul-
monary disease was noted. Further-
more, blood absorption was actively
used for patients with a preoperativeardiovascular Surgery c July 2011risk of postoperative myasthenic crisis
or those who experienced a postopera-
tive myasthenic crisis.
Second, they described the tips on
continuous tracheal intubation (for 48
hours) in patients with myasthenia
gravis after thymectomy to prevent tra-
cheal incision for myasthenic crisis. In
their study most of the postoperative
myasthenic crisis occurred within 2
days after thymectomy; however, in
our study it occurred within an average
of 5 days (range, 1–17 days) after thy-
mectomy. In addition, the rateofpostop-
erative myasthenic crisis within 2 days
after thymectomy was only 35.7% of
patients with postoperative myasthenic
crisis. Therefore in our study most pa-
tients could have adverse effects from
the use of continuous tracheal intuba-
tion. We preferred early extubation ra-
therthan continuous intubation to
prevent pulmonary complications.
Third, Deng and colleagues re-
vealed that the strong predictors of
myasthenic crisis included pulmonary
complications, Osserman typing of IIb
or greater, malignant thymoma, and
preoperative oral dose of pyridostig-
mine bromide of greater than 480
mg/d. Only Osserman typing of IIb
or greater (ie, bulbar symptom) was
the common predictor between the 2
studies. The differences were a result
of the differences in surgical ap-
proach, perioperative management,
and so on. Recently, our group per-
formed thymectomy with video-
assisted thoracoscopic surgery on 17
patients with myasthenia gravis, and
none of them experienced postopera-
tive myasthenic crisis.
Finally, it is important to know the
risksof postoperativemyasthenic crisis
in accordance with the situation, such
as surgical approach, perioperative
management, and patient selection.
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To the Editor:
We read with great interest a recent
meta-analysis by Yan and associates1
of randomized and norandomized stud-
ies of percutaneous coronary interven-
tion with drug-eluting stents (DESs)y among patients with multivessel disease assigned to
ass grafting (CABG). Asterisk indicates that the stu
l disease; 3VD, triple-vessel disease; CARDia, Coron
ntervention with Taxus and Cardiac Surgery trial.5
of Thoracic and Cardiovascular Surgeversus coronary artery bypass grafting
(CABG) for coronary artery disease,
including not only multivessel disease
(MVD) but also single-vessel disease
or left main coronary artery disease.
This meta-analysis,1 as well as a previ-
ous meta-analysis of MVD,2 demon-
strated no difference in all-cause
mortality at least 1 year after DES and
CABG treatments. Although thesepercutaneous coronary intervention (PCI) with
dy provided an adjusted odds ratio. IV, Inverse
ary Artery Revascularization in Diabetes trial4;
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